Official Title

A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine

Study Summary

38 million people suffer from migraine headaches. Are you one of them? If so, Bioclinica Research in Orlando is now enrolling volunteers to participate in a migraine research study. The purpose of this study is to evaluate safety and tolerability of BHV3000 (rimegepant).

Eligibility and Recruitment Information

Recruitment Status Recruiting
Eligible Genders Both
Eligible Ages 18 and up
Inclusion Subjects with 4 - 14 moderate to severe migraines per month.
Exclusion History of HIV disease.
Start Date
Compensation Variable
Location Orlando, FL

Study Information

Condition Migraine

Administrative Information

Study ID NCT03266588

Apply for this study

Please include your first name.
Please include your last name.
Please include a valid email address.
Thank you for applying.
Sorry, something wen't wrong. Please contact us for support.